plx9486
Small moleculeexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
4
Phase 3
1
Phase 4
0
Earliest trial started Mar 1, 2015 (NCT02401815)
Timeline
Indications
Mechanism of action
- Stem cell growth factor receptorINHIBITOR
KIT inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- plx9486
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05208047 | Phase 3 | Apr 14, 2022 | Cogent Biosciences |
| NCT04996875 | Phase 2 | Nov 9, 2021 | Cogent Biosciences |
| NCT05186753 | Phase 2 | Oct 26, 2021 | Cogent Biosciences |
| NCT02401815 | Phase 1/Phase 2 (Phase 2) | Mar 1, 2015 | Plexxikon |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Cogent Biosciences | For profit | 3 | 3 | 2 | 2021 |
| Plexxikon | For profit | 1 | 1 | 1 | 2015 |
2 organizations
Page 1 / 1